基于Nomogram预测模型分析住院患儿多重耐药菌感染的危险因素
Analysis of Risk Factors for Multidrug-Resistant Bacterial Infections in Hospitalized Children Based on Nomogram Prediction Model
摘要: 目的:分析住院患儿多重耐药菌(MDRO)感染的分布情况及医院感染的危险因素,方法:收集2020年3月~2023年3月中山市人民医院儿科住院病房共61例患儿的临床资料进行回顾性分析。收集MDRO感染患儿61例,同时匹配各病区非MDRO感染患儿61例。收集各病区感染患儿的基本感染临床资料,对所有患儿资料进行单因素及多因素Logistic回归分析。利用R4.3.1软件构建MDRO感染风险的列线图模型,并通过受试者工作特征曲线和校准曲线评价模型的预测拟合效果。结果:PICU和NICU是MDRO常发生的病区,分别占52.46%和29.51%,下呼吸道和血液系统是MDRO常发生的感染部位,分别占42.62%和29.50%。耐青耐碳青霉烯类大肠埃希菌(CRE)和耐甲氧西林金黄色葡萄球菌(MASA)是最常见的感染菌株,分别占24%和17%。长时间住院、长时间使用抗生素和侵入性操作是儿科各病区MDRO感染的独立危险因素(P < 0.05)。基于Logistic回归分析结果构建的列线图模型,受试者工作特征曲线下面积为0.834,95%置信区间:0.766~0.901,Hosmer-Lemeshow检验显示χ2 = 139.69,P = 0.332,且校准曲线预测发生率与实测发生率之间偏差小,模型校准度好、预测拟合效果好。结论:长时间住院、长时间使用抗生素和侵入性操作是儿科各病区MDRO感染的独立危险因素感染的独立危险因素。基于危险因素构建的风险预测模型具有良好的预测能力,可以为及时采取预防性感染控制措施提供参考。
Abstract: Objective: To analyze the distribution of multidrug-resistant bacteria (MDRO) infection in hospitalized children and the risk factors for hospital acquired infections. Method: Clinical data of 61 hospitalized children in the pediatric ward of Zhongshan People’s Hospital from March 2020 to March 2023 were collected for retrospective analysis. Collect 61 cases of MDRO infected children and match 61 cases of non MDRO infected children in each ward. Collect basic clinical data of infected children in each ward, and conduct univariate and multivariate logistic regression analysis on all patient data. Construct a column chart model for MDRO infection risk using R4.3.1 software, and evaluate the predictive fitting effect of the model through subject working characteristic curves and calibration curves. As a result, PICU and NICU are the wards where MDRO often occurs, accounting for 52.46% and 29.51% respectively. The lower respiratory tract and blood system are the sites of infection where MDRO often occurs, accounting for 42.62% and 29.50% respectively. Penicillin resistant Escherichia coli (CRE) and methicillin-resistant Staphylococcus aureus (MASA) are the most common strains of infection, accounting for 24% and 17%, respectively. Long term hospitalization, prolonged use of antibiotics, and invasive procedures are independent risk factors for MDRO infection in various pediatric wards (P < 0.05). The column chart model constructed based on the results of logistic regression analysis showed that the area under the working characteristic curve of the subjects was 0.834, with a 95% confidence interval of 0.766~0.901. The Hosmer Lemeshow test showed χ2 = 139.69, P = 0.332, and the deviation between the predicted and measured incidence rates of the calibration curve was small, indicating good model calibration and prediction fitting effect. Conclusion: Long term hospitalization, prolonged use of antibiotics, and invasive procedures are independent risk factors for MDRO infection in various pediatric wards. The risk prediction model based on risk factors has good predictive ability and can provide reference for timely adoption of preventive infection control measures.
文章引用:袁贯平, 黄惠娟, 丁俊彩, 杨佩珊, 杨秀芳. 基于Nomogram预测模型分析住院患儿多重耐药菌感染的危险因素[J]. 医学诊断, 2024, 14(4): 407-414. https://doi.org/10.12677/md.2024.144059

参考文献

[1] 刘世华, 马乐龙, 印爱珍, 等. 多学科协作在儿童多重耐药菌医院感染防控中的应用[J]. 中国感染控制杂志, 2021, 20(6): 550-556.
[2] Meropol, S.B., Haupt, A.A. and Debanne, S.M. (2017) Incidence and Outcomes of Infections Caused by Multidrug-Resistant Enterobacteriaceae in Children, 2007-2015. Journal of the Pediatric Infectious Diseases Society, 7, 36-45. [Google Scholar] [CrossRef] [PubMed]
[3] El-Nawawy, A., Ashraf, G.A., Antonios, M.A.M., Meheissen, M.A. and El-Alfy, M.M.R. (2018) Incidence of Multidrug-Resistant Organism among Children Admitted to Pediatric Intensive Care Unit in a Developing Country. Microbial Drug Resistance, 24, 1198-1206. [Google Scholar] [CrossRef] [PubMed]
[4] Mahony, M., McMullan, B., Brown, J. and Kennedy, S.E. (2019) Multidrug-resistant Organisms in Urinary Tract Infections in Children. Pediatric Nephrology, 35, 1563-1573. [Google Scholar] [CrossRef] [PubMed]
[5] Flannery, D.D., Chiotos, K., Gerber, J.S. and Puopolo, K.M. (2021) Neonatal Multidrug-Resistant Gram-Negative Infection: Epidemiology, Mechanisms of Resistance, and Management. Pediatric Research, 91, 380-391. [Google Scholar] [CrossRef] [PubMed]
[6] 杨昊, 刘长秀, 李童. 2018-2020年岳阳市儿童常见多重耐药菌感染及耐药性分析[J]. 甘肃医药, 2023, 42(10): 897-899.
[7] 吕婧雯, 田本顺, 银晓聪, 等. 2012-2020年广州地区肺炎链球菌耐药趋势增高及聚集性多重耐药模式[J]. 南京医科大学学报(自然科学版), 2022, 42(6): 854-860.
[8] 刘艳, 马丹娟, 黄瑞玉, 等. 新生儿重症监护病房多重耐药革兰阴性菌血流感染危险因素回归分析[J]. 检验医学与临床, 2019, 16(6): 783-785.
[9] Newman, A.M. and Arshad, M. (2020) The Role of Probiotics, Prebiotics and Synbiotics in Combating Multidrug-Resistant Organisms. Clinical Therapeutics, 42, 1637-1648. [Google Scholar] [CrossRef] [PubMed]
[10] Hsu, A.J. and Tamma, P.D. (2014) Treatment of Multidrug-Resistant Gram-Negative Infections in Children. Clinical Infectious Diseases, 58, 1439-1448. [Google Scholar] [CrossRef] [PubMed]
[11] 卫生部办公厅. 卫生部办公厅关于印发《多重耐药菌医院感染预防与控制技术指南(试行)》的通知[J]. 中华人民共和国卫生部公报, 2011(2): 59-61.
[12] 江梅, 黎毅敏, 郑劲平. GRADE方法在呼吸机相关性肺炎诊断、预防和治疗指南制定中的应用[J]. 中国循证医学杂志, 2014, 14(7): 897-900.
[13] 血管导管相关感染预防与控制指南(2021版) [J]. 中国感染控制杂志, 2021, 20(4): 387-388.
[14] 中华人民共和国卫生部. 医院感染诊断标准(试行) [J]. 中华医学杂志, 2001, 81(5): 314-320.
[15] 卫生部北京医院. 全国临床检验操作规程[Z]. 1999.
[16] Rodriguez, B.A., Girotto, J.E. and Nicolau, D.P. (2018) Ceftazidime/avibactam and Ceftolozane/Tazobactam: Novel Therapy for Multidrug Resistant Gram Negative Infections in Children. Current Pediatric Reviews, 14, 97-109. [Google Scholar] [CrossRef] [PubMed]
[17] Gargiullo, L., Del Chierico, F., D’Argenio, P. and Putignani, L. (2019) Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives. Frontiers in Microbiology, 10, Article 1704. [Google Scholar] [CrossRef] [PubMed]
[18] Williams, P.C. (2020) Potential of Fosfomycin in Treating Multidrug‐Resistant Infections in Children. Journal of Paediatrics and Child Health, 56, 864-872. [Google Scholar] [CrossRef] [PubMed]
[19] 谢朝云, 熊芸, 覃家露, 等. 儿童细菌性重症肺炎多重耐药菌感染相关因素分析[J]. 中国儿童保健杂志, 2018, 26(3): 325-328.
[20] 李敏敏, 邝舒敏, 黄冬平, 等. 儿童重症监护室多重耐药菌主动筛查分布分析[J]. 广东医学, 2020, 41(24): 2559-2563.
[21] 雷宏莹, 吴玮哲. 临床药师参与经口咽齿状突切除术后多重耐药铜绿假单胞菌感染儿童会诊1例[J]. 中国医药科学, 2023, 13(14): 191-194.
[22] 谢朝云, 蒙桂鸾, 李耀福, 等. 新生儿败血症死亡与多重耐药菌感染相关性的回顾性巢式病例对照研究[J]. 西北国防医学杂志, 2020, 41(2): 103-108.
[23] 卢蔚薇, 赖宇涛, 童雅婵, 等. 新生儿重症监护病房多重耐药菌反复感染的危险因素分析[J]. 传染病信息, 2023, 36(3): 243-247.
[24] 许丽君. 新生儿重症监护病房多重耐药菌感染情况及其血流感染的危险因素分析[J]. 中外医学研究, 2023, 21(25): 86-91.
[25] 刘巍巍, 焦颖, 张巍, 等. 重症监护室新生儿鲍曼不动杆菌侵袭性感染临床特征及药敏分析[J]. 中国临床医生杂志, 2019, 47(8): 975-978.
[26] Cies, J.J., Palladino, C., Mahmood, H., Moore, W.S. and Chopra, A. (2020) Targeted Multidrug Resistant Organism Antimicrobial Prophylaxis and Postoperative Infections in Pediatric Cardiothoracic Surgical Patients. Pediatric Infectious Disease Journal, 39, 514-518. [Google Scholar] [CrossRef] [PubMed]